EquiPrEP: An implementation science protocol for promoting equitable access and uptake of long-acting injectable HIV pre-exposure prophylaxis (LAI-PrEP)

Background Long-acting injectable HIV pre-exposure prophylaxis (LAI-PrEP) was approved by the U.S. Food and Drug Administration in December 2021. This initial phase of implementation represents a prime opportunity to ensure equitable LAI-PrEP provision to communities often underrepresented in PrEP c...

Full description

Saved in:

Bibliographic Details
Published in:	PloS one Vol. 18; no. 9; p. e0291657
Main Authors:	Kaul, Christina M, Moore, Brandi E, Kaplan-Lewis, Emma, Casey, Eunice, Pitts, Robert A, Pagan Pirallo, Patricia, Lim, Sahnah, Kapadia, Farzana, Cohen, Gabriel M, Khan, Maria, Mgbako, Ofole
Format:	Journal Article
Language:	English
Published:	San Francisco Public Library of Science 19-09-2023 Public Library of Science (PLoS)
Subjects:	Biology and Life Sciences Clinics Community Disease prevention Drug approval Epidemics Gender identity Hispanic Americans HIV HIV (Viruses) Hospital systems Hospitals Human immunodeficiency virus Indigent care Leadership Medicine and health sciences Men Patients People and places Pharmacy Populations Prevention Primary care Prophylaxis Research and Analysis Methods Retention Sexually transmitted diseases STD Study Protocol Transgender people Transgender persons Uninsured people Verbal communication Women United States New York United States > US
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!